Physician profile
Robert C Lee
NPI 1699716118
$3,160.71
in general payments reported to CMS, 2019-2025
16 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2021: $98.84 · 2022: $169 · 2023: $382 · 2024: $889 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,383.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,816.09 | 2019-2025 | Clareon, Ngenuity, Luxor |
| Tarsus Pharmaceuticals, INC. | $208.95 | 2024-2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $194.32 | 2025 | Eylea Hd |
| Rxsight INC | $162.42 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $123.93 | 2023 | Miebo |
| Glaukos Corporation | $114.05 | 2019-2025 | Idose, Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $103.35 | 2019-2025 | Tecnis Iol |
| Integra Lifesciences Corporation | $98.84 | 2021 | |
| Coopervision INC. | $72.99 | 2022 | |
| Aerie Pharmaceuticals, INC. | $66.33 | 2019 | |
| Astellas Pharma US INC | $52.21 | 2025 | Izervay |
| New World Medical,INC. | $42.87 | 2019 | |
| Sun Pharmaceutical Industries INC. | $41.61 | 2019 | |
| Sight Sciences, INC. | $24.70 | 2019 | |
| Nestle Healthcare Nutrition INC. | $21.71 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.34 | 2025 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.